|
|
Article: EP MedSystems Begins Enrollment in ICE CHIP Intracardiac Ultrasound Clinical Trial.
- Article from:
- Business Wire
- Article date:
- May 3, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST BERLIN, N.J. -- EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used in cardiac rhythm management, announced today initiation of the landmark ICE-CHIP(TM) (Intracardiac Echocardiograhpy guided Cardioversion to Help Interventional Procedures) multicenter clinical trial. This is EP MedSystems first clinical trial involving intracardiac ultrasound (ICE). The ICE CHIP trial, is a sequential Phase I and Phase II worldwide clinical trial, which compares the cardiac imaging capabilities of ICE during a cardiac catheterization procedure with standard transesophageal echocardiography (TEE), a separate standalone procedure in Phase 1. In Phase ...
Related newspaper, magazine, and journal articles:
|
|
Article: EP MedSystems Receives European Approval for ALERT ...
Business Wire;
November 24, 2003 ;
700+ words
... ... BUSINESS WIRE)--Nov. 24, 2003 EP MedSystems, Inc. (Nasdaq: EPMD), a market ... be difficult with a fixed catheter. EP MedSystems' President & CEO Reinhard Schmidt ... approval is a significant achievement for EP MedSystems, and allows us to begin selling the ...
|
|